ISI NucMed 2022 – Du 3 au 6 juin 2023, Nantes
During four days, 20 participants will deepen their knowledge in some of the main research areas in nuclear medicine, with
A look back at … the Cancer and Work Meeting
The conference “Living and working with cancer” was held on Wednesday 23 November at the Cité des sciences et de
REWORK: A toolbox to facilitate the return to work
After 5 years of research, the REWORK programme of SIRIC ILIAD is about to release a toolbox for patients with
SIRIC ILIAD is proud to count Philippe Moreau as one of the most influential researchers in the world 2022
The annual Clarivate – Highly Cited Researchers ranking has, for the seventh consecutive year, recognised Professor Philippe Moreau, Director of
Modeling tumor development and progression: From PDXs to cancer organoids | A colloquium sponsored by SIRIC ILIAD
On October 18th, the French PDX network and the Organoids research group organised, with the support of the SIRIC ILIAD
New AF3M newsletter: AIDES & RIGHTS
As part of the National Multiple Myeloma Information Day (JNM 2022) of the AF3M (Association Française des Malades du Myélome
A look back at the National Multiple Myeloma Information Day – JNM 2022 | AF3M
On Saturday 15 October, SIRIC ILIAD was present at the National Information Day on Multiple Myeloma (JNM 2022) of the
SIRIC ILIAD shares its research progress with its partners | SIRIC Review 2018-2022
The SIRIC ILIAD Partners Committee met on Monday 17 October 2022 to present the results of the 5 years of
Teclistamab: a promising new treatment for multiple myeloma
Last August, Professor Philippe Moreau, haematologist and director of SIRIC ILIAD, published a scientific article in the prestigious New England
Nuclear medicine in Nantes at the SNMMI 2022 Meeting
A film on the Nantes nuclear medicine cluster is being shown throughout the SNMMI international congress being held in Vancouver
